Correlation Between Apogee Therapeutics, and Quantum Si

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Quantum Si at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Quantum Si into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and Quantum Si incorporated, you can compare the effects of market volatilities on Apogee Therapeutics, and Quantum Si and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Quantum Si. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Quantum Si.

Diversification Opportunities for Apogee Therapeutics, and Quantum Si

-0.51

Correlation Coefficient

Apogee Therapeutics,  Quantum Si

Excellent diversification

The 3 months correlation between Apogee and Quantum is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Quantum Si incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum Si incorporated and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Quantum Si. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum Si incorporated has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Quantum Si go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Quantum Si

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Quantum Si. But the stock apears to be less risky and, when comparing its historical volatility, Apogee Therapeutics, Common is 6.84 times less risky than Quantum Si. The stock trades about -0.02 of its potential returns per unit of risk. The Quantum Si incorporated is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  9.61  in Quantum Si incorporated on September 3, 2024 and sell it today you would earn a total of  27.39  from holding Quantum Si incorporated or generate 285.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.31%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  Quantum Si incorporated

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Quantum Si incorporated

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Si incorporated are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quantum Si showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Apogee Therapeutics, and Quantum Si

The main advantage of trading using opposite Apogee Therapeutics, and Quantum Si positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Quantum Si can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum Si will offset losses from the drop in Quantum Si's long position.

The idea behind Apogee Therapeutics, Common and Quantum Si incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.